Taipei, Taiwan – With BIONET Corp. becoming the second company in Taiwan to receive approval from the Ministry of Health and Welfare (MOHW) to legally use human-derived exosomes as cosmetic raw materials and commercialize them, the Taiwan market is expected to see an increasing number of cosmetic and skincare products containing legally approved human exosomes, offering consumers more choices.

IMDERMA LABORATORIES’ Expertise and Congratulations to BIONET Corp.
At IMDERMA LABORATORIES CO., LTD., we have accumulated years of experience in exosome regulatory compliance and third-party testing, and we are honored to have participated in the safety verification process of the exosome ingredient that has now obtained approval for use.
We also assisted BIONET Corp. in completing the INCI application and successfully obtaining the official designation of “Exosomes.” We sincerely congratulate BIONET Corp. on achieving this significant milestone in both regulatory advancement and industry development.

Commitment to Diverse Ingredient Development and Global Standards
In addition, we actively promote INCI applications and safety and efficacy validations for a wide range of raw materials, including those derived from plants and animals, peptides, and synthetic compounds.
Our company operates a BSL-2 certified laboratory, having passed inspections by the Taiwan CDC and the Hsinchu City Health Bureau. As an SBIR Excellent Award recipient in Hsinchu City, we maintain a long-term collaboration with MatTek Corporation (USA) to jointly promote international-level testing and standards.

Looking Ahead
We will continue to build on a foundation of science and precision to provide professional support for Taiwan’s cosmetic raw material and exosome industries, working together with the industry to achieve healthy and sustainable development.

Source: https://news.cnyes.com/news/id/6165245

Learn more about our services： https://bit.ly/4muibLr